TARSUS PHARMACEUTICALS INC filings

All
Holdings
Significant ownership
Insider transactions
Annual reports
Quarterly reports
Events
Shareholder votes
SEC filings by TARSUS PHARMACEUTICALS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-14RTW INVESTMENTS, LPTarsus Pharmaceuticals, Inc.3,152,3419.5%EDGAR
SC 13G/A2024-02-14Cormorant Asset Management, LPTarsus Pharmaceuticals, Inc.1,600,000-EDGAR
SC 13G/A2024-02-14TANG CAPITAL PARTNERS LPTarsus Pharmaceuticals, Inc.2,204,7976.7%EDGAR
SC 13G/A2024-02-13Vivo Capital IX, LLCTarsus Pharmaceuticals, Inc.894,8262.7%EDGAR
SC 13G2024-02-09MORGAN STANLEYTarsus Pharmaceuticals, Inc.1,943,7055.9%EDGAR
SC 13G/A2024-02-02Cowen Financial Products LLCTarsus Pharmaceuticals, Inc.1,911,3995.8%EDGAR
SC 13G/A2024-02-02TimesSquare Capital Management, LLCTarsus Pharmaceuticals, Inc.00.0%EDGAR
SC 13G2024-01-26BlackRock Inc.Tarsus Pharmaceuticals, Inc.2,515,1247.6%EDGAR
SC 13G2024-01-22Paradigm Biocapital Advisors LPTarsus Pharmaceuticals, Inc.1,927,5065.8%EDGAR
SC 13G2023-05-05Cowen Financial Products LLCTarsus Pharmaceuticals, Inc.1,398,9835.2%EDGAR
SC 13G/A2023-02-14RTW INVESTMENTS, LPTarsus Pharmaceuticals, Inc.2,548,1259.6%EDGAR
SC 13G/A2023-02-14Cormorant Asset Management, LPTarsus Pharmaceuticals, Inc.1,115,000-EDGAR
SC 13G/A2023-02-14PERCEPTIVE ADVISORS LLCTarsus Pharmaceuticals, Inc.1,296,4164.9%EDGAR
SC 13G/A2023-02-14Vivo Capital IX, LLCTarsus Pharmaceuticals, Inc.2,262,2008.5%EDGAR
SC 13G/A2023-02-14TANG CAPITAL PARTNERS LPTarsus Pharmaceuticals, Inc.2,001,5857.5%EDGAR
SC 13G/A2023-02-10Flynn James ETarsus Pharmaceuticals, Inc.1,324,2145.0%EDGAR
SC 13G2023-02-09BlackRock Inc.Tarsus Pharmaceuticals, Inc.1,326,5314.9%EDGAR
SC 13G2023-02-08BlackRock Inc.Tarsus Pharmaceuticals, Inc.1,341,2595.0%EDGAR
SC 13G2023-02-03TimesSquare Capital Management, LLCTarsus Pharmaceuticals, Inc.1,429,3105.4%EDGAR
SC 13G2022-05-13TANG CAPITAL PARTNERS LPTarsus Pharmaceuticals, Inc.2,091,7537.9%EDGAR
External links